NOS3 and hemorrhage: As therapeutic intervention, 17b-estradiol benzoate (E2) was reported to attenuate vasospasm and preserve the eNOS expression by activating estrogen receptor subtype a (ERa) in a rat double-hemorrhage model [38,62].